vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Walker & Dunlop, Inc. (WD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $340.0M, roughly 1.5× Walker & Dunlop, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -12.9%, a 19.7% gap on every dollar of revenue. On growth, Walker & Dunlop, Inc. posted the faster year-over-year revenue change (-0.4% vs -1.7%). Over the past eight quarters, Walker & Dunlop, Inc.'s revenue compounded faster (22.1% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Walker & Dunlop, Inc. is one of the largest commercial real estate finance and advisory services firms in the United States and internationally.
MD vs WD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $340.0M |
| Net Profit | $33.7M | $-13.9M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | -17.2% |
| Net Margin | 6.8% | -12.9% |
| Revenue YoY | -1.7% | -0.4% |
| Net Profit YoY | 10.5% | -131.0% |
| EPS (diluted) | $0.40 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $340.0M | ||
| Q3 25 | $492.9M | $337.7M | ||
| Q2 25 | $468.8M | $319.2M | ||
| Q1 25 | $458.4M | $237.4M | ||
| Q4 24 | $502.4M | $341.5M | ||
| Q3 24 | $511.2M | $292.3M | ||
| Q2 24 | $504.3M | $270.7M | ||
| Q1 24 | $495.1M | $228.1M |
| Q4 25 | $33.7M | $-13.9M | ||
| Q3 25 | $71.7M | $33.5M | ||
| Q2 25 | $39.3M | $34.0M | ||
| Q1 25 | $20.7M | $2.8M | ||
| Q4 24 | $30.5M | $44.8M | ||
| Q3 24 | $19.4M | $28.8M | ||
| Q2 24 | $-153.0M | $22.7M | ||
| Q1 24 | $4.0M | $11.9M |
| Q4 25 | 9.9% | -17.2% | ||
| Q3 25 | 13.8% | 13.6% | ||
| Q2 25 | 12.8% | 14.5% | ||
| Q1 25 | 7.0% | 2.2% | ||
| Q4 24 | 7.8% | 15.3% | ||
| Q3 24 | 6.6% | 12.8% | ||
| Q2 24 | -31.3% | 10.4% | ||
| Q1 24 | 3.2% | 6.0% |
| Q4 25 | 6.8% | -12.9% | ||
| Q3 25 | 14.5% | 9.9% | ||
| Q2 25 | 8.4% | 10.6% | ||
| Q1 25 | 4.5% | 1.2% | ||
| Q4 24 | 6.1% | 13.1% | ||
| Q3 24 | 3.8% | 9.9% | ||
| Q2 24 | -30.3% | 8.4% | ||
| Q1 24 | 0.8% | 5.2% |
| Q4 25 | $0.40 | $-0.41 | ||
| Q3 25 | $0.84 | $0.98 | ||
| Q2 25 | $0.46 | $0.99 | ||
| Q1 25 | $0.24 | $0.08 | ||
| Q4 24 | $0.37 | $1.32 | ||
| Q3 24 | $0.23 | $0.85 | ||
| Q2 24 | $-1.84 | $0.67 | ||
| Q1 24 | $0.05 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $299.3M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $1.7B |
| Total Assets | $2.2B | $5.1B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $299.3M | ||
| Q3 25 | $340.1M | $274.8M | ||
| Q2 25 | $224.7M | $233.7M | ||
| Q1 25 | $99.0M | $181.0M | ||
| Q4 24 | $229.9M | $279.3M | ||
| Q3 24 | $103.8M | $179.8M | ||
| Q2 24 | $19.4M | $208.1M | ||
| Q1 24 | $8.0M | $216.5M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $1.7B | ||
| Q3 25 | $890.7M | $1.8B | ||
| Q2 25 | $833.8M | $1.8B | ||
| Q1 25 | $789.2M | $1.7B | ||
| Q4 24 | $764.9M | $1.7B | ||
| Q3 24 | $732.5M | $1.7B | ||
| Q2 24 | $706.5M | $1.7B | ||
| Q1 24 | $856.2M | $1.7B |
| Q4 25 | $2.2B | $5.1B | ||
| Q3 25 | $2.2B | $5.8B | ||
| Q2 25 | $2.1B | $4.7B | ||
| Q1 25 | $2.0B | $4.5B | ||
| Q4 24 | $2.2B | $4.4B | ||
| Q3 24 | $2.1B | $4.6B | ||
| Q2 24 | $2.0B | $4.2B | ||
| Q1 24 | $2.2B | $3.8B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $-664.3M |
| Free Cash FlowOCF − Capex | — | $-680.1M |
| FCF MarginFCF / Revenue | — | -200.0% |
| Capex IntensityCapex / Revenue | — | 4.6% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-2.2B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $-664.3M | ||
| Q3 25 | $137.3M | $-948.1M | ||
| Q2 25 | $137.2M | $-238.5M | ||
| Q1 25 | $-117.5M | $-281.1M | ||
| Q4 24 | $133.0M | $129.4M | ||
| Q3 24 | $91.8M | $-202.0M | ||
| Q2 24 | $107.0M | $-237.8M | ||
| Q1 24 | $-125.2M | $38.4M |
| Q4 25 | — | $-680.1M | ||
| Q3 25 | — | $-950.4M | ||
| Q2 25 | — | $-241.0M | ||
| Q1 25 | — | $-284.7M | ||
| Q4 24 | — | $116.4M | ||
| Q3 24 | — | $-204.0M | ||
| Q2 24 | — | $-241.7M | ||
| Q1 24 | — | $35.2M |
| Q4 25 | — | -200.0% | ||
| Q3 25 | — | -281.5% | ||
| Q2 25 | — | -75.5% | ||
| Q1 25 | — | -120.0% | ||
| Q4 24 | — | 34.1% | ||
| Q3 24 | — | -69.8% | ||
| Q2 24 | — | -89.3% | ||
| Q1 24 | — | 15.4% |
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | -28.34× | ||
| Q2 25 | 3.49× | -7.02× | ||
| Q1 25 | -5.66× | -102.07× | ||
| Q4 24 | 4.36× | 2.89× | ||
| Q3 24 | 4.72× | -7.01× | ||
| Q2 24 | — | -10.49× | ||
| Q1 24 | -31.03× | 3.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
WD
Segment breakdown not available.
